Sign in

CIK 0001720893

  • Non-accelerated filer
  • Smaller reporting company

BioXcel Therapeutics, Inc.

Sign in to watch
Ticker
BTAIQ
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821386754
Phone
+1 203-643-8060
Business address
555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
  1. 4 Exercise or conversion Chief Scientific Officer acquired 521 shares (option exercise)
  2. 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
  3. 4 Exercise or conversion Rodriguez Javier acquired 521 shares (option exercise)
  4. 4 Exercise or conversion Chief Medical Officer acquired 521 shares (option exercise)
  5. 4 Exercise or conversion CEO and President acquired 2,610 shares (option exercise)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Exercise or conversion Rodriguez Javier acquired 521 shares (option exercise)
  12. 4 Exercise or conversion Chief Scientific Officer acquired 521 shares (option exercise)
  13. 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
  14. 4 Planned sale CEO and President sold 60,000 shares at an average $20.86 ($1,251,727)
  15. 4 Exercise or conversion Chief Medical Officer acquired 521 shares (option exercise)
  16. 4 Planned sale CEO and President sold 6,500 shares at $25.79 ($167,641)
  17. 4 Exercise or conversion CEO and President acquired 15,000 shares (option exercise)
  18. 4 Planned sale Chief Financial Officer sold 5,000 shares at $27.17 ($135,864)
  19. 4 Planned sale Rodriguez Javier sold 1,785 shares at $27.32 ($48,765)
  20. 3 Insider Initial Statement of Ownership

Page 7 of 14 · 276 filings